- Home
- SLGL vs WEA Comparison
SLGL vs WEA Comparison
Compare SLGL & WEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SLGL | WEA |
|---|---|---|
| Founded | 1997 | 2002 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 117.8M | 130.2M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | SLGL | WEA |
|---|---|---|
| Price | $68.81 | $11.25 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $50.00 | N/A |
| AVG Volume (30 Days) | 21.8K | ★ 46.1K |
| Earning Date | 11-20-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.87% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $18,970,000.00 | N/A |
| Revenue This Year | $122.71 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 62.04 | N/A |
| 52 Week Low | $4.02 | $9.60 |
| 52 Week High | $71.99 | $11.29 |
Technical Indicators
Market Signals| Indicator | SLGL | WEA |
|---|---|---|
| Relative Strength Index (RSI) | 81.92 | 64.30 |
| Support Level | $60.20 | $11.16 |
| Resistance Level | $71.99 | $11.37 |
| Average True Range (ATR) | 4.55 | 0.10 |
| MACD | 2.18 | 0.02 |
| Stochastic Oscillator | 85.92 | 74.39 |
Price Performance
Historical ComparisonAbout SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.
About WEA Western Asset Bond Fund Share of Beneficial Interest
Western Asset Premier Bond Fund is a diversified closed-end management investment company. Its investment objective is to provide current income and capital appreciation by investing in a diversified portfolio of investment-grade bonds. The Fund invests in sectors, such as financials, energy, telecommunication services, consumer discretionary, healthcare, materials, information technology, and consumer staples.